PHARMACOLOGICAL ACTIVATION OF THE p53 PATHWAY BY NUTLIN-3 EXERTS ANTI-TUMORAL EFFECTS IN MEDULLOBLASTOMAS

被引：0

作者：

Kuenkele, Annette ^{[1
]}

De Preter, Katleen ^{[2
]}

Heukamp, Lukas ^{[3
]}

Thor, Theresa ^{[1
]}

Pajtler, Kristian ^{[1
]}

Hartmann, Wolfgang ^{[3
]}

Mittelbronn, Michel ^{[4
]}

Grotzer, Michael ^{[5
]}

Deubzer, Hedwig ^{[6
]}

Speleman, Frank ^{[2
]}

Schramm, Alexander ^{[1
]}

Eggert, Angelika ^{[1
]}

Schulte, Johannes ^{[1
]}

机构：

[1] Univ Childrens Hosp Essen, Essen, Germany

[2] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium

[3] Univ Hosp Cologne, Inst Pathol, Cologne, Germany

[4] Goethe Univ Frankfurt, Inst Neurol, Frankfurt, Germany

[5] Childrens Hosp Zurich, Zurich, Switzerland

[6] German Canc Res Ctr, D-6900 Heidelberg, Germany

来源：

NEURO-ONCOLOGY | 2012年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：88 / 88

页数：1

共 50 条

[1] Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas
Kuenkele, Annette
De Preter, Katleen
Heukamp, Lukas
Thor, Theresa
Pajtler, Kristian W.
Hartmann, Wolfgang
Mittelbronn, Michel
Grotzer, Michael A.
Deubzer, Hedwig E.
Speleman, Frank
Schramm, Alexander
Eggert, Angelika
Schulte, Johannes H.
NEURO-ONCOLOGY, 2012, 14 (07) : 859 - 869
[2] Pharmacological activation of the p53 pathway by nutlin-3 inhibits medulloblastoma cell proliferation in vitro and in vivo
Kuenkele, Annette
de Preter, Katleen
Vandesompele, Jo
Thor, Theresa
Pajtler, Kristian
Hartmann, Wolfgang
Heukamp, Lukas
Schramm, Alexander
Eggert, Angelika
Schulte, Johannes H.
EUROPEAN JOURNAL OF PEDIATRICS, 2011, 170 (02) : 267 - 268
[3] PHARMACOLOGIC ACTIVATION OF THE P53 PATHWAY BY NUTLIN-3 INHIBITS MEDULLOBLASTOMA CELL PROLIFERATION IN VITRO
Kuenkele, Annette
de Preter, Katleen
Vandesompele, Jo
Pajtler, Kristian
Heukamp, Lukas
Grotzer, Michael
Schramm, Alexander
Eggert, Angelika
Schulte, Johannes
PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 918 - 918
[4] Pharmacologic activation of the p53 pathway using Nutlin-3 inhibits medulloblastoma cell proliferation in vitro
Kuenkele, A.
Baumann, M.
Odersky, A.
Deubzer, H.
Witt, O.
Eggert, A.
Schramm, A.
Schulte, J. H.
KLINISCHE PADIATRIE, 2009, 221 (03): : 201 - 201
[5] Awakening p53 in senescent cells using nutlin-3
Schug, Thaddeus T.
AGING-US, 2009, 1 (10): : 842 - 844
[6] Anticancer effects of the p53 activator nutlin-3 in Ewing's sarcoma cells
Sonnemann, Juergen
Palani, Chithra D.
Wittig, Susan
Becker, Sabine
Eichhorn, Friederike
Voigt, Astrid
Beck, James F.
EUROPEAN JOURNAL OF CANCER, 2011, 47 (09) : 1432 - 1441
[7] Pharmacological activation of the p53 pathway by a new compound CYZ2017 exerts anti-tumor effects
Han, Yuqiao
Ren, Ziwei
Wu, Yixin
Chen, Yunzhong
Cui, Zhenmei
Zhu, Tong
Ma, Mingliang
Du, Yijie
Dong, Suzhen
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (04) : 1069 - 1075
[8] Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3
M H Aziz
H Shen
C G Maki
Oncogene, 2011, 30 : 4678 - 4686
[9] A Stapled p53 Helix Targets HDMX to Overcome Nutlin-3 Resistance and Reactivate the p53 Tumor Suppressor Pathway in Cancer
Bernal, Federico
Wade, Mark
Silverstein, Amy M.
Verdine, Gregory L.
Wahl, Geoffrey M.
Walensky, Loren D.
BLOOD, 2008, 112 (11) : 915 - 915
[10] Nutlin-3 and Velcade Synergistically Induce Cell Cycle Arrest and Apoptosis in Multiple Myeloma through Activation of p53 Pathway
Saha, M. N.
Jayakar, J.
Chang, H.
LABORATORY INVESTIGATION, 2009, 89 : 284A - 284A

← 1 2 3 4 5 →